<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27821592</article-id>
<article-id pub-id-type="pmc">5207175</article-id>
<article-id pub-id-type="publisher-id">M116.749697</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M116.749697</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth<xref ref-type="fn" rid="FN1">*</xref></article-title>
<alt-title alt-title-type="short">BET Inhibitors Induce Cartilage Destruction</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Niu</surname>
<given-names>Ningning</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shao</surname>
<given-names>Rui</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Guang</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zou</surname>
<given-names>Weiguo</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the State Key Laboratory of Cell Biology, Chinese Academy of Sciences Center for Excellence in Molecular Cell Sciences, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> A scholar of the National 1000 Young Talents Program of China and the National Science Fund for Excellent Young Scholars (Grant 81322027). To whom correspondence should be addressed: <addr-line>Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Rd., SIBCB Bldg., Rm. 1401, Shanghai 200031, China.</addr-line> Tel.: <phone>86-21-54921320</phone>; Fax: <fax>86-21-54921279</fax>; E-mail: <email>zouwg94@sibcb.ac.cn</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Xiao-Fan Wang</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>23</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>7</day>
<month>11</month>
<year>2016</year>
</pub-date>
<volume>291</volume>
<issue>52</issue>
<fpage>26647</fpage>
<lpage>26657</lpage>
<history>
<date date-type="received">
<day>21</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>5</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Â© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc05216026647.pdf"></self-uri>
<abstract>
<p>Small molecule inhibitors for bromodomain and extra-terminal (BET) proteins have recently emerged as potential therapeutic agents in clinical trials for various cancers. However, to date, it is unknown whether these inhibitors have side effects on bone structures. Here, we report that inhibition of BET bromodomain proteins may suppress chondrocyte differentiation and restrain bone growth. We generated a luciferase reporter system using the chondrogenic cell line ATDC5 in which the luciferase gene was driven by the promoter of <italic>Col2a1</italic>, an elementary collagen of the chondrocyte. The <italic>Col2a1</italic>-luciferase ATDC5 system was used for rapidly screening both activators and repressors of human collagen <italic>Col2a1</italic> gene expression, and we found that BET bromodomain inhibitors reduce the <italic>Col2a1</italic>-luciferase. Consistent with the luciferase assay, BET inhibitors decrease the expression of <italic>Col2a1</italic>. Furthermore, we constructed a zebrafish line in which the enhanced green fluorescent protein (EGFP) expression was driven by <italic>col2a1</italic> promoter. The transgenic (<italic>col2a1</italic>-EGFP) zebrafish line demonstrated that BET inhibitors I-BET151 and (+)-JQ1 may affect EGFP expression in zebrafish. Furthermore, we found that I-BET151 and (+)-JQ1 may affect chondrocyte differentiation <italic>in vitro</italic> and inhibit zebrafish growth <italic>in vivo</italic>. Mechanistic analysis revealed that BET inhibitors influenced the depletion of RNA polymerase II from the <italic>Col2a1</italic> promoter. Collectively, these results suggest that BET bromodomain inhibition may have side effects on skeletal bone structures.</p>
</abstract>
<kwd-group>
<kwd>anticancer drug</kwd>
<kwd>bone</kwd>
<kwd>cartilage</kwd>
<kwd>chondrocyte</kwd>
<kwd>epigenetics</kwd>
<kwd>BET inhibitors</kwd>
<kwd>Col2a1</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>Ministry of Science and Technology of the People's Republic of China
<named-content content-type="funder-id">http://dx.doi.org/10.13039/501100002855</named-content></funding-source>
<award-id>2015CB964503</award-id>
<award-id>2014CB964704</award-id>
</award-group>
<award-group id="award2">
<funding-source>National Natural Science Foundation of China
<named-content content-type="funder-id">http://dx.doi.org/10.13039/501100001809</named-content></funding-source>
<award-id>31371463</award-id>
<award-id>31501170</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>